Efforts towards the identification of simpler platensimycin analogues-the total synthesis of oxazinidinyl platensimycin

Chemistry - A European Journal

Volumn 15, Issue 12, 2009, Pages 2747-2750

  Wang, Jingxin ^a   Lee, Vincent ^a   Sintim, Herman O ^a  

^a Bldg 142   (United States)

Author keywords

Antibiotics enzymes; Medicinal chemistry; Platensimycin; Ring closing metathesis; Total synthesis

Indexed keywords

ANTIBIOTICS; CATALYSTS; ESTERS;

BIOLOGICAL TESTING; CORE STRUCTURES; MEDICINAL CHEMISTRY; METHYL ESTERS; PLATENSIMYCIN; RING-CLOSING METATHESIS; TOTAL SYNTHESIS;

ENZYMES;

ADAMANTANE; AMINOBENZOIC ACID DERIVATIVE; ANILIDE; ANTIINFECTIVE AGENT; PLATENSIMYCIN;

ARTICLE; CATALYSIS; CHEMICAL STRUCTURE; CHEMISTRY; CYCLIZATION; SYNTHESIS;

ADAMANTANE; AMINOBENZOIC ACIDS; ANILIDES; ANTI-BACTERIAL AGENTS; CATALYSIS; CYCLIZATION; MOLECULAR STRUCTURE;

EID: 62349119695     PISSN: 09476539     EISSN: 15213765     Source Type: Journal    
DOI: 10.1002/chem.200802568     Document Type: Article

References (36)

1. J. Wang, S. M. Soisson, K. Young, W. Shoop, S. Kodali, A. Galgoci, R. Painter, G. Parthasaralhy, Y. S. Tang, R. Cummings, S. Ha, K. Dorso, M. Motyl, H. Jayasuriya, J. Ondeyka, K. Herath, C. Zhang, L. Hernandez, J. Allocco, A. Basilio. J. R. Tormo, O. Genilloud, F. Vicente, F. Pelaez, L. Colwell, S. H. Lee, B. Michael, T. Felcetto, C. Gill, L. L. Silver, J. D. Hermes. K. Bartizal, J. Barrett, D. Schmatz, J. W. Becker, D. Cully, S. B. Singh. Nature 2006, 441, 358-361.
2. C. Walsh, Nat. Rev. Microbiol. 2003, 1, 65-70.
3. For a review, see: a) K. Tiefenbacher, J. Mulzer, Angew. Chem. 2008, 120, 2582-2590;
4. Angew. Chem. Int. Ed. 2008, 47, 2548-2555;
5. for total syntheses and synthetic studies towards platensimycin, see: b) K.C. Nicolaou, A. Li, D.J. Edmonds, Angew. Chem. 2006, 118, 7244-7248;
6. Angew. Chem. Int. Ed. 2006, 45, 7086-7090:
7. c) K. C. Nicolaou, D. J. Edmonds, A. Li, G. S. Tria, Angew. Chem. 2007, 119, 4016-4019;
8. Angew. Chem. Int. Ed. 2007, 46, 3942-3945;
9. d) G. Lalic, E. J. Corey, Org. Lett. 2007, 9, 4921-4923;
10. e) Y. Zou. C.-H. Chen, C. D. Taylor, B. M. Foxman, B. B. Snider, Org. Lett. 2007, 9, 1825-1828:
11. f) P. Li, J. N. Payette, H. Yamamoto, J. Am. Chem. Soc. 2007, 129, 9534-9535:
12. g) K. P. Kaliappan, V. Ravikumar, Org. Lett. 2007, 9, 2417-2419;
13. h) A. K. Ghosh, K. Xi, Org. Lett. 2007, 9, 4013-4016:
14. i) K. Tiefenbacher, J. Mulzer, Angew. Chem. 2007, 119, 8220-8221:
15. Angew. Chem. Int. Ed. 2007, 46, 8074-8075:
16. j) C. H. Kim, K.P. Jang, S. Y. Choi, Y. K. Chung, E. Lee, Angew. Chem. 2008, 120, 4073-4075:
17. Angew. Chem. Int. Ed. 2008, 47, 4009-4011.
18. For the biological activity of recently synthesized platensimycin analogues, see: a) K. C. Nicolaou, T. Lister, R. M. Denton, A. Montero, D.J. Edmonds, Angew. Chem. 2007, 119, 4796-4798;
19. Angew. Chem. Int. Ed. 2007, 46, 4712-4714;
20. b) K. C. Nicolaou, A. F. Stepan, T. Lister, A. Li, A. Montero, G. S. Tria, C. I. Turner, Y. Tang, J. Wang, R. M. Denton, D. J. Edmonds, J. Am. Chem. Soc. 2008, 130, 13110-13119.
21. The carbamate moiety of the oxazinidinyl ring can maintain the hydrogen-bonding interactions with A309 of ecFabF. The oxazinidinyl ring is however not strictly an isosteric replacement of the enone ring core of platensimycin due to the lack of the C4 methyl group found in the parent compound.
22. S. H. Hong, D. P. Sanders, C. W. Lee, R. H. Grubbs, J. Am. Chem. Soc. 2005, 127, 17160-17161.
23. a) M. Chérest, H. Felkin, N. Prudent, Tetrahedron Lett. 1968, 9, 2199-2204:
24. b) A. Mengel, O. Reiser, Chem. Rev. 1999, 99, 1191-1223.
25. a) J. M. Hahn, W. J. Le Noble, J. Am. Chem. Soc. 1992, 114, 1916-1917:
26. b) M. Xie, W. J. Le Noble, J. Org. Chem. 1989, 54, 3836-3839:
27. c) G. Mehta, F.A. Khan, J. Am. Chem. Soc. 1990, 112, 6140-6142:
28. d) G. Mehta, F. A. Khan, B. Ganguly, J. Chandrasekhar, Chem. Commun. 1992, 1711-1712;
29. e) R. L. Halterman, M. A. McEvoy, J. Am. Chem. Soc. 1990, 112, 6690-6693.
30. a) A. S. Cieplak, J. Am. Chem. Soc. 1981, 103, 4540-4552;
31. b) A.S. Cieplak, B.D. Tait, C.R. Johnson, A Am. Chem. Soc. 1989, 111, 8447-8462.
32. The reductive amination was conducted in the polar protic solvent. MeOH; therefore dipole minimization might not play as great a role in product distribution.
33. 1.
34. Dihydroplatensimycin, an analogue that lacks the enone moiety, is less active than platensimycin. Also, this keto analogue is unstable and forms cyclized products. See: S. B. Singh, H. Jayasuriya. J. G. Ondeyka, K. B. Herath, C. Zhang, D. L. Zink, N. N. Tsou, R. G. Ball, A. Basilio, O. Genilloud, M. T. Diez, F. Vicente, F. Pelaez, K. Young, J. Wang, J. Am. Chem. Soc. 2006, 128, 11916-11920:
35. S. B. Singh, H. Jayasuriya, J. G. Ondeyka, K. B. Herath, C Zhang, D. L. Zink, N. N. Tsou, R. G. Ball, A. Basilio, O. Genilloud, M. T. Diez, F. Vicente, F. Pelaez, K. Young, J. Wang, J. Am. Chem. Soc. 2006, 128, 15547.
36. Platensimycin methyl ester is also not a potent antibiotic, see: S. B. Singh, K. B. Herath, J. Wang, N. Tsou, R. G. Ball, Tetrahedron Lett. 2007, 48, 5429-5433.